Refractory Leukemia

Refractory Leukemia is a subtype of pediatric leukemia characterized by the failure to achieve remission after initial induction therapy, distinguishing it from responsive forms by its persistent malignant proliferation despite standard treatment protocols.

1.4K

Publications

101K

Citations

9.2K

Authors

2.1K

Institutions

Publications per year

2017–2026

444

Authors

9.2K

  1. HM
    Hagop M. Kantarjian

    The University of Texas MD Anderson Cancer Center, United States

    149 publications · 14.2K citations

    59

    h-index

  2. JE
    Jörge E. Cortes

    The University of Texas MD Anderson Cancer Center, United States

    90 publications · 8.5K citations

    42

    h-index

  3. FR
    Farhad Ravandi

    The University of Texas MD Anderson Cancer Center, United States

    66 publications · 4K citations

    34

    h-index

  4. GG
    Guillermo Garcia‐Manero

    The University of Texas MD Anderson Cancer Center, United States

    55 publications · 4.8K citations

    33

    h-index

  5. MJ
    Michael J. Keating

    The University of Texas MD Anderson Cancer Center, United States

    48 publications · 4.8K citations

    32

    h-index

1–5 of 9.2K

Venues

  1. Blood

    249 publications · 21.5K citations

    77

    h-index

  2. Journal of Clinical Oncology

    116 publications · 13.1K citations

    66

    h-index

  3. PubMed

    Repository · 130 publications · 6.8K citations

    43

    h-index

  4. Cancer

    77 publications · 5K citations

    41

    h-index

  5. Leukemia

    39 publications · 3.3K citations

    33

    h-index

1–5